top of page
Lecanemab For Treating Alzheimer’s Disease: New Clinical Trial Results from Patients with Early-Stage Disease
LuMind IDSC has noted that there remain substantial barriers to Leqembi being deemed safe and accessible for people with Down syndrome, as no one with Down syndrome was included in the Leqembi clinical trials to date. LuMind IDSC recommends that a safety study specifically geared to people with Down syndrome should take place prior to widespread use in the Down community.
bottom of page